Trials / Unknown
UnknownNCT06176976
Preoperative Administration of Lugols Solution in Toxic Thyroid Diseases (TD): A Prospective Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Aristotle University Of Thessaloniki · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Lugol's solution and other preparations containing iodide have been used as an adjuvant treatment in patients with toxic disease planned for thyroidectomy. However, no conclusive evidence supporting the benefits of preoperative treatment with LS for patients with toxic goiters. This trial aims to provide new insights into future recommendations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Lugol's iodine solution 5% | 4 drops of LS every 8 hours for 10 days preoperatively will be given |
Timeline
- Start date
- 2023-12-15
- Primary completion
- 2025-01-01
- Completion
- 2025-06-01
- First posted
- 2023-12-20
- Last updated
- 2023-12-20
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT06176976. Inclusion in this directory is not an endorsement.